E-cadherin gene mutations in human gastric carcinoma cell lines - PubMed (original) (raw)
E-cadherin gene mutations in human gastric carcinoma cell lines
T Oda et al. Proc Natl Acad Sci U S A. 1994.
Abstract
Reduced expression of E-cadherin has been regarded as one of the main molecular events involved in dysfunction of the cell-cell adhesion system, triggering cancer invasion and metastasis. However, even with a sufficient amount of E-cadherin, cell-cell adhesion is sometimes lost in "diffusely invasive" human carcinomas. Ten human cancer cell lines, showing growth characterized morphologically by loose cell-cell adhesion, were analyzed for possible structural abnormalities of their expressed E-cadherin. Four of the cell lines showed strong mRNA and protein expression with no nucleotide sequence abnormalities, and mRNA was absent in four other cell lines. mRNA sequence was abnormal in the remaining two gastric carcinoma cell lines. In MKN45 (poorly differentiated adenocarcinoma), this involved a 12-bp in-frame deletion with strong expression of mRNA and protein. In KATO-III (signet ring cell carcinoma), there were four mRNA species with insertions of different sizes, among which the major transcripts (with a 7-bp insertion) caused a frameshift, and expression of both mRNA and protein was markedly reduced. In these two cell lines, DNA mutations were detected around exon-intron junctions, revealing that aberrant RNA splicing was the cause of the mRNA abnormalities. In addition, the wild-type allele of the E-cadherin locus was lost, suggesting that the E-cadherin gene had been inactivated by two hits (mutation and allele loss), similar to the mechanism for inactivation of tumor suppressor genes.
Similar articles
- Alterations of the cadherin-catenin cell adhesion system in cancers.
Kanai Y, Oda T, Shimoyama Y, Ochiai A, Oyama T, Yoshiura K, Akimoto S, Yamada T, Hirohashi S. Kanai Y, et al. Princess Takamatsu Symp. 1994;24:51-62. Princess Takamatsu Symp. 1994. PMID: 8983063 Review. - Inactivation of the E-cadherin gene in primary gastric carcinomas and gastric carcinoma cell lines.
Tamura G, Sakata K, Nishizuka S, Maesawa C, Suzuki Y, Iwaya T, Terashima M, Saito K, Satodate R. Tamura G, et al. Jpn J Cancer Res. 1996 Nov;87(11):1153-9. doi: 10.1111/j.1349-7006.1996.tb03125.x. Jpn J Cancer Res. 1996. PMID: 9045944 Free PMC article. - Characterization of a mutant E-cadherin protein encoded by a mutant gene frequently seen in diffuse-type human gastric carcinoma.
Fukudome Y, Yanagihara K, Takeichi M, Ito F, Shibamoto S. Fukudome Y, et al. Int J Cancer. 2000 Nov 15;88(4):579-83. doi: 10.1002/1097-0215(20001115)88:4<579::aid-ijc10>3.0.co;2-u. Int J Cancer. 2000. PMID: 11058874 - E-cadherin gene mutations provide clues to diffuse type gastric carcinomas.
Becker KF, Atkinson MJ, Reich U, Becker I, Nekarda H, Siewert JR, Höfler H. Becker KF, et al. Cancer Res. 1994 Jul 15;54(14):3845-52. Cancer Res. 1994. PMID: 8033105 - Mutations of the human E-cadherin (CDH1) gene.
Berx G, Becker KF, Höfler H, van Roy F. Berx G, et al. Hum Mutat. 1998;12(4):226-37. doi: 10.1002/(SICI)1098-1004(1998)12:4<226::AID-HUMU2>3.0.CO;2-D. Hum Mutat. 1998. PMID: 9744472 Review.
Cited by
- Trends of Early _Helicobacter pylori_-Uninfected Gastric Cancer in an Aging Regional Area.
Maeda H, Sasaki F, Ooi T, Uehara S, Yano H, Sameshima Y, Fukuda Y, Nasu Y, Fujino Y, Shigeta K, Fujita H, Tanaka A, Kanmura S, Ido A. Maeda H, et al. J Clin Med. 2024 Mar 21;13(6):1827. doi: 10.3390/jcm13061827. J Clin Med. 2024. PMID: 38542051 Free PMC article. - Molecular pathological approach to cancer epigenomics and its clinical application.
Kanai Y. Kanai Y. Pathol Int. 2024 Apr;74(4):167-186. doi: 10.1111/pin.13418. Epub 2024 Mar 14. Pathol Int. 2024. PMID: 38482965 Free PMC article. Review. - Constitutive Occurrence of E:N-cadherin Heterodimers in Adherens Junctions of Hepatocytes and Derived Tumors.
Gerber TS, Ridder DA, Schindeldecker M, Weinmann A, Duret D, Breuhahn K, Galle PR, Schirmacher P, Roth W, Lang H, Straub BK. Gerber TS, et al. Cells. 2022 Aug 12;11(16):2507. doi: 10.3390/cells11162507. Cells. 2022. PMID: 36010583 Free PMC article. - N-Cadherin Distinguishes Intrahepatic Cholangiocarcinoma from Liver Metastases of Ductal Adenocarcinoma of the Pancreas.
Gerber TS, Goeppert B, Hausen A, Witzel HR, Bartsch F, Schindeldecker M, Gröger LK, Ridder DA, Cahyadi O, Esposito I, Gaida MM, Schirmacher P, Galle PR, Lang H, Roth W, Straub BK. Gerber TS, et al. Cancers (Basel). 2022 Jun 23;14(13):3091. doi: 10.3390/cancers14133091. Cancers (Basel). 2022. PMID: 35804866 Free PMC article. - Potential therapeutic targets discovery by transcriptome analysis of an in vitro human gastric signet ring carcinoma model.
Yamaguchi K, Yoshihiro T, Ariyama H, Ito M, Nakano M, Semba Y, Nogami J, Tsuchihashi K, Yamauchi T, Ueno S, Isobe T, Shindo K, Moriyama T, Ohuchida K, Nakamura M, Nagao Y, Ikeda T, Hashizume M, Konomi H, Torisu T, Kitazono T, Kanayama T, Tomita H, Oda Y, Kusaba H, Maeda T, Akashi K, Baba E. Yamaguchi K, et al. Gastric Cancer. 2022 Sep;25(5):862-878. doi: 10.1007/s10120-022-01307-8. Epub 2022 Jun 4. Gastric Cancer. 2022. PMID: 35661943
References
- Int J Cancer. 1973 May;11(3):765-73 - PubMed
- Cancer Res. 1992 Sep 15;52(18):5104-9 - PubMed
- Cancer Res. 1978 May;38(5):1345-55 - PubMed
- Br J Cancer. 1979 Jan;39(1):15-23 - PubMed
- Cancer Res. 1979 Mar;39(3):1020-5 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases